FrontPage is India's Stock Market Social Network

Join 50,000+ Traders and Investors

GUFICBIO

78

+2.45 (3.24%)

Updated 03:28 02/07 IST

GUFICBIO Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for GUFICBIO

0% Bullish

0% Bearish

GUFICBIO Buy or Sell - Brokerage Reports

No. of reports in last year

0

No. of analysts

0

Average Consensus Forecast

Consensus Potential

0.00%

See GUFICBIO Share Price Targets >>

GUFICBIO Ratings

Long term GUFICBIO rating by FrontPage users

★
★
★
★
★
★
★
★
★
★

0/5 (0 Ratings)0

Find answers to all your questions on live GUFICBIO message board: Is GUFICBIO buy or sell? Should I buy GUFICBIO shares? Why are GUFICBIO shares falling? Should I invest in GUFICBIO stock?

Home
GUFICBIO Forum

GUFICBIO Share Price Discussion

King999 @king999

Reputation: 16,496 • Jun 10 8:41 AM

Type
Buy
Instrument
GUFICBIO
Entry Price
₹68.2
Price@Trade
₹68.2
Target Price
₹80
Stop Price
₹61
Valid Till
Jun 17, 2020 3:20 AM 
Margin
₹68,200 approx for 1000 Qty
Status
Active
#GUFICBIO 

Like

Reply

Marketguru @marketguru

Reputation: 10,407 • Jun 3 4:33 AM

Type
Buy
Instrument
GUFICBIO
Entry Price
₹66.4
Price@Trade
₹66.75
Target Price
₹85
Stop Price
₹59
Valid Till
Jun 10, 2020 3:20 AM 
Margin
₹19,920 approx for 300 Qty
Status
Exited
Exit Price
₹62.95
Net P&L
-₹1,035 (-5.2%)
#GUFICBIO 

Like

Reply (2)

Latest replies

TrackerBot @trackerbot

•

Jun 3 4:34 AM

Update
Trade Entered
Entry Price
₹66.4

Marketguru @marketguru

•

Jun 3 8:54 AM

Update
Exited
Exit Price
₹62.95
Net P&L
-₹1,035 (-5.2%)

ROHAN @rohan9401

Reputation: 1,952 • May 29 7:13 AM

Type
Buy
Instrument
GUFICBIO
Entry Price
₹54
Price@Trade
₹54
Target Price
₹80
Stop Price
₹40
Valid Till
May 28, 2021 3:20 AM 
Margin
₹54,000 approx for 1000 Qty
Status
Exited
Exit Price
₹55
Net P&L
+₹1,000 (+1.85%)
#GUFICBIO 

Like

Reply (1)

Latest replies

ROHAN @rohan9401

•

Jun 2 2:48 AM

Update
Exited
Exit Price
₹55
Net P&L
+₹1,000 (+1.85%)

NewsBot @newsbot

Reputation: 3,388 • Oct 3, 2019 2:38 AM

Miracle aging treatment Botox set to face fight from this little-known Indian firm
BSE-listed Gulfic Biosciences has received approvals to manufacture and sell Botulinum toxin, better known by popular brand name Botox.

Moneycontrol

https://www.moneycontrol.com/news/business/companies/mira...
#GUFICBIO 

Like

Reply

Join FrontPage

FrontPage is India's favorite stock discussions community

Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.

GUFICBIO - Share Price - Fundamentals
Market Capitalization 837.86
Enterprise Value 910.45
Price to Earnings 52.3
Price to Book Value 15.66
Return on Capital Employed 0.29
Return on Equity 0.3
Face Value 1
Dividend Yield NA
GUFICBIO Share Price - Technicals
GUFICBIO Share Price - Historical (₹)
Date Open High Low Close
Jul 2 75.6 79.7 75.05 77.5
Jul 1 77 78 75 75.55
Jun 30 76.95 80.5 76.05 76.4
Jun 29 77.1 82 75.8 77
Jun 26 80.85 82.25 77.25 78.95
GUFICBIO Share Price - Daily Moving Averages (DMA)
20 Day Moving Average ₹72.74
30 Day Moving Average ₹67.53
50 Day Moving Average ₹64.51
100 Day Moving Average ₹62.16
200 Day Moving Average ₹64.26
GUFICBIO - Profit And Loss
CONSOLIDATED Mar-18 Mar-17 % Change
Revenue 300.96 249.27 0.21
Operating Profit 38.16 26.97 0.41
Profit Before Tax 29.54 18.02 0.64
Net Income 16.02 11.41 0.4
GUFICBIO - Balance Sheet
CONSOLIDATED Mar-18 Mar-17 % Change
Shareholder's Funds 53.52 44.91 0.19
Total Liabilities 182.55 134.41 0.36
Total Assets 236.07 179.32 0.32
GUFICBIO - Cash Flow
CONSOLIDATED Mar-18 Mar-17 % Change
Cash from Operating Activity -4.85 -4.4 0.1
Cash from Investing Activity -8.84 -3.32 1.66
Cash from Financing Activity 14.49 7.09 1.04
Net Cash Flow 0.8 -0.63 -2.27
GUFICBIO - Ratios
CONSOLIDATED Mar-18 Mar-17
Return on Assets 0.07 0.06
Return on Equity 0.3 0.25
Return on Capital Employed 0.29 0.24
GUFICBIO - 3 year Growth
3 Year CAGR Growth in Revenue 0.99
3 Year CAGR Growth in Operating Profit 1.67
3 Year CAGR Growth in EBIDTA 1.88
3 Year CAGR Growth in Net Income 2.85
3 Yr CAGR Growth - Diluted EPS 2.83
GUFICBIO - 5 year Growth
5 Year CAGR Growth in Revenue 2.01
5 Year CAGR Growth in Operating Profit 2.55
5 Year CAGR Growth in EBIDTA 2.84
5 Year CAGR Growth in Net Income 3.81
3 Yr CAGR Growth - Diluted EPS 3.81
GUFICBIO - Recent News
NewsBot
Oct 3, 2019 2:38 AM
Miracle aging treatment Botox set to face fight from this little-known Indian firm
Moneycontrol
GUFICBIO - Related Communities
SUNPHARMA
Sun Pharmaceutical Industries Ltd. NS...
AUROPHARMA
Aurobindo Pharma Ltd. NSE: AUROPHARMA...
CIPLA
Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
BIOCON
Biocon Ltd. NSE: BIOCON | BSE: 532523...
LUPIN
Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
DRREDDY
Dr. Reddy's Laboratories Ltd. NSE: DR...
GLENMARK
Glenmark Pharmaceuticals Ltd. NSE: GL...
PEL
Piramal Enterprises Ltd. NSE: PEL | B...
DIVISLAB
Divi's Laboratories Ltd. NSE: DIVISLA...
APOLLOHOSP
Apollo Hospitals Enterprise Ltd. NSE:...

SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

Privacy•Terms•••

FrontPage © 2020